Moderna Struggles with COVID-19 Vaccine Market Share, Pipeline Progress, Morgan Stanley Says

USA
EnglishUK
EnglishIndia
EnglishAustralia
EnglishCanada
EnglishFrance
FrançaisSuisse
FrançaisEspaña
EspañolDeutschland
DeutschÖsterreich
DeutschSchweiz
DeutschBelgië
NederlandsNederland
NederlandsItalia
ItalianoSverige
Svenska
Market Closed -
Other stock markets
|
After market 06:07:09 pm | |||
35.75 USD | +8.37% |
|
36.00 | +0.70% |
Feb. 18 | Barclays Downgrades Moderna to Equalweight From Overweight, Adjusts Price Target to $45 From $111 | MT |
Feb. 17 | Moderna, Oddo BHF remains positive, but reduces its target | CF |